Rapid Micro Biosystems, Inc.
NASDAQ:RPID
1.26 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 22.519 | 17.133 | 23.232 | 16.077 | 16.512 |
| Cost of Revenue
| 28.004 | 25.673 | 30.973 | 24.148 | 16.746 |
| Gross Profit
| -5.485 | -8.54 | -7.741 | -8.071 | -0.234 |
| Gross Profit Ratio
| -0.244 | -0.498 | -0.333 | -0.502 | -0.014 |
| Reseach & Development Expenses
| 12.82 | 12.866 | 9.781 | 6.531 | 5.429 |
| General & Administrative Expenses
| 24.936 | 26.819 | 17.895 | 9.976 | 8.924 |
| Selling & Marketing Expenses
| 13.322 | 14.994 | 11.815 | 5.962 | 4.047 |
| SG&A
| 38.258 | 41.813 | 29.71 | 15.938 | 12.971 |
| Other Expenses
| -0.083 | 0.059 | -0.808 | 0.022 | 0.016 |
| Operating Expenses
| 51.078 | 54.679 | 39.491 | 22.469 | 18.4 |
| Operating Income
| -56.563 | -63.219 | -47.232 | -30.54 | -18.634 |
| Operating Income Ratio
| -2.512 | -3.69 | -2.033 | -1.9 | -1.129 |
| Total Other Income Expenses Net
| 4.127 | 1.837 | -26.201 | -6.404 | -2.11 |
| Income Before Tax
| -52.436 | -61.382 | -73.433 | -36.944 | -20.744 |
| Income Before Tax Ratio
| -2.329 | -3.583 | -3.161 | -2.298 | -1.256 |
| Income Tax Expense
| 0.031 | -0.576 | 0.091 | 0.134 | 0.427 |
| Net Income
| -52.467 | -60.806 | -73.524 | -37.078 | -21.171 |
| Net Income Ratio
| -2.33 | -3.549 | -3.165 | -2.306 | -1.282 |
| EPS
| -1.22 | -1.43 | -1.77 | -0.96 | -0.53 |
| EPS Diluted
| -1.22 | -1.43 | -1.77 | -0.96 | -0.53 |
| EBITDA
| -53.458 | -63.219 | -46.511 | -29.009 | -17.158 |
| EBITDA Ratio
| -2.374 | -3.69 | -2.002 | -1.804 | -1.039 |